Zdrowie i gospodarka · 17/02/2004

FDA Releases Draft Guidance for Estrogen Drug Products

The Food and Drug Administration (FDA) has made available a draft guidance document to help healthcare providers and patients understand labeling requirements for noncontraceptive estrogen medications used to treat vasomotor symptoms and vaginal/vulvar atrophy symptoms.